Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy

I. Gataa; L. Mezquita; C. Rossoni; E. Auclin; M. Kossai; F. Aboubakar; S. Le Moulec; J. Masse; M. Masson; N. Radosevic-Robin; P. Alemany; M. Rouanne; V. Bluthgen; L. Hendriks; C. Caramella; A. Gazzah; D. Planchard; J.P. Pignon; B. Besse; J. Adam

doi:10.1016/j.ejca.2020.10.017

Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy

I. Gataa, L. Mezquita, C. Rossoni, E. Auclin, M. Kossai, F. Aboubakar, S. Le Moulec, J. Masse, M. Masson, N. Radosevic-Robin, P. Alemany, M. Rouanne, V. Bluthgen, L. Hendriks, C. Caramella, A. Gazzah, D. Planchard, J.P. Pignon, B. Besse, J. Adam^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	221-229
Number of pages	9
Journal	European Journal of Cancer
Volume	145
DOIs	https://doi.org/10.1016/j.ejca.2020.10.017
Publication status	Published - 1 Mar 2021

Keywords

Immunotherapy
Immune checkpoint inhibitor
Nivolumab
Tumor-infiltrating lymphocytes
TIL
Lung cancer
Nonesmall cell lung cancer
NSCLC
Prognostic
Biomarkers

Access to Document

10.1016/j.ejca.2020.10.017

Cite this

Gataa, I., Mezquita, L., Rossoni, C., Auclin, E., Kossai, M., Aboubakar, F., Le Moulec, S., Masse, J., Masson, M., Radosevic-Robin, N., Alemany, P., Rouanne, M., Bluthgen, V., Hendriks, L., Caramella, C., Gazzah, A., Planchard, D., Pignon, J. P., Besse, B., & Adam, J. (2021). Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy. European Journal of Cancer, 145, 221-229. https://doi.org/10.1016/j.ejca.2020.10.017

Gataa, I. ; Mezquita, L. ; Rossoni, C. ; Auclin, E. ; Kossai, M. ; Aboubakar, F. ; Le Moulec, S. ; Masse, J. ; Masson, M. ; Radosevic-Robin, N. ; Alemany, P. ; Rouanne, M. ; Bluthgen, V. ; Hendriks, L. ; Caramella, C. ; Gazzah, A. ; Planchard, D. ; Pignon, J.P. ; Besse, B. ; Adam, J. / Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy. In: European Journal of Cancer. 2021 ; Vol. 145. pp. 221-229.

@article{dfb923fb16804ede8b15dc723958492e,

title = "Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy",

keywords = "Immunotherapy, Immune checkpoint inhibitor, Nivolumab, Tumor-infiltrating lymphocytes, TIL, Lung cancer, Nonesmall cell lung cancer, NSCLC, Prognostic, Biomarkers",

author = "I. Gataa and L. Mezquita and C. Rossoni and E. Auclin and M. Kossai and F. Aboubakar and {Le Moulec}, S. and J. Masse and M. Masson and N. Radosevic-Robin and P. Alemany and M. Rouanne and V. Bluthgen and L. Hendriks and C. Caramella and A. Gazzah and D. Planchard and J.P. Pignon and B. Besse and J. Adam",

year = "2021",

month = mar,

day = "1",

doi = "10.1016/j.ejca.2020.10.017",

language = "English",

volume = "145",

pages = "221--229",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "ELSEVIER SCI LTD",

}

Gataa, I, Mezquita, L, Rossoni, C, Auclin, E, Kossai, M, Aboubakar, F, Le Moulec, S, Masse, J, Masson, M, Radosevic-Robin, N, Alemany, P, Rouanne, M, Bluthgen, V, Hendriks, L, Caramella, C, Gazzah, A, Planchard, D, Pignon, JP, Besse, B & Adam, J 2021, 'Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy', European Journal of Cancer, vol. 145, pp. 221-229. https://doi.org/10.1016/j.ejca.2020.10.017

Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy. / Gataa, I.; Mezquita, L.; Rossoni, C.; Auclin, E.; Kossai, M.; Aboubakar, F.; Le Moulec, S.; Masse, J.; Masson, M.; Radosevic-Robin, N.; Alemany, P.; Rouanne, M.; Bluthgen, V.; Hendriks, L.; Caramella, C.; Gazzah, A.; Planchard, D.; Pignon, J.P.; Besse, B.; Adam, J.

In: European Journal of Cancer, Vol. 145, 01.03.2021, p. 221-229.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy

AU - Gataa, I.

AU - Mezquita, L.

AU - Rossoni, C.

AU - Auclin, E.

AU - Kossai, M.

AU - Aboubakar, F.

AU - Le Moulec, S.

AU - Masse, J.

AU - Masson, M.

AU - Radosevic-Robin, N.

AU - Alemany, P.

AU - Rouanne, M.

AU - Bluthgen, V.

AU - Hendriks, L.

AU - Caramella, C.

AU - Gazzah, A.

AU - Planchard, D.

AU - Pignon, J.P.

AU - Besse, B.

AU - Adam, J.

PY - 2021/3/1

Y1 - 2021/3/1

KW - Immunotherapy

KW - Immune checkpoint inhibitor

KW - Nivolumab

KW - Tumor-infiltrating lymphocytes

KW - TIL

KW - Lung cancer

KW - Nonesmall cell lung cancer

KW - NSCLC

KW - Prognostic

KW - Biomarkers

U2 - 10.1016/j.ejca.2020.10.017

DO - 10.1016/j.ejca.2020.10.017

M3 - Article

C2 - 33516050

VL - 145

SP - 221

EP - 229

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -